Minimum 20 minute delay
12/17/2014 10:01:28 AMDUBLIN, Ireland--(BUSINESS WIRE)--Dec. 17, 2014-- In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a significant clinical benefit when compared to pharmaceutical treatment alone. Results from the …
12/17/2014 7:57:26 AMInnovative design of wireless, vitamin-sized capsule recognized for its profound impact on improving the standard-of-care for small bowel examinations NEW YORK--(BUSINESS WIRE)--Dec. 17, 2014-- PillCam® SB, Covidien’s wireless capsule endoscope, is now featured in the exhibit, “…
12/11/2014 8:51:12 AMDUBLIN, Ireland--(BUSINESS WIRE)--Dec. 11, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on December 10, 2014, the Company’s issued share capital, excluding treasury shares, consisted of 453,773,707 ordinary shares, par value …
Covidien in the News
A Partner in Health
Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.